Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Diagnostic Criteria and Monitoring for Euglycemic Diabetic Ketoacidosis (DKA)

Essential Diagnostic Criteria

  • The American Diabetes Association recommends that euglycemic DKA be diagnosed based on elevated blood β-hydroxybutyrate (bOHB) levels, with a preferred cutoff value of ≥6.3 mmol/L, in combination with evidence of metabolic acidosis, indicated by venous pH <7.3 and serum bicarbonate <18 mEq/L 1, 2
  • The diagnostic criteria for euglycemic DKA include blood glucose <200 mg/dL, elevated bOHB, venous pH <7.3, serum bicarbonate <18 mEq/L, and elevated anion gap (>12 mEq/L) 3, 2
  • The American Association of Clinical Endocrinologists recommends a comprehensive laboratory evaluation, including blood glucose, serum β-hydroxybutyrate (bOHB), venous blood gases, serum electrolytes, serum bicarbonate, and calculation of anion gap, to diagnose and monitor euglycemic DKA 3, 4, 5
  • Blood urea nitrogen (BUN) and creatinine should be measured to assess renal function in patients with euglycemic DKA 4, 5

Monitoring During Treatment

  • The Endocrine Society recommends monitoring blood glucose, electrolytes, BUN, creatinine, venous pH, and anion gap every 2-4 hours during treatment of euglycemic DKA 4, 2
  • Blood bOHB is the preferred method for monitoring ketosis resolution, with decreasing levels indicating improvement 1, 2

Criteria for Resolution of Euglycemic DKA

  • Resolution of euglycemic DKA is indicated by normalized anion gap (≤12 mEq/L), serum bicarbonate ≥18 mEq/L, venous pH >7.3, and decreasing blood bOHB levels 2, 4, 1